Financial Statements

management discussion and analysis

/ MD-and-A /

Management discussion and analysis, usually shortened to MD&A, is the part of an annual report where the company's leaders explain the numbers in their own words. The financial statements tell you what happened; the MD&A is management's chance to tell you why, and what it expects next. It is the difference between reading a thermometer and hearing the doctor explain what the fever means.

A good MD&A walks through the year's results — why revenue rose or fell, what drove costs, how the cash position changed — and then looks forward to known trends, risks, and uncertainties the bare statements cannot show. For example, the income statement might show profit slipping; the MD&A is where management explains it was due to a one-time factory move and that margins should recover. For public companies, regulators require this section and expect candid discussion, including bad news, not just cheerleading.

The MD&A is valuable because it adds context and forward-looking color that numbers alone lack, and it can flag trouble early. But read it with a clear eye: it is written by the same management whose performance it describes, so it tends toward an optimistic spin. The disciplined approach is to cross-check the MD&A's claims against the audited statements and notes, trusting the story more where the numbers back it up.

The income statement shows operating profit down 20%. The MD&A explains this came from a one-off $3 million plant relocation and states that, excluding it, profit actually grew — context the raw number could never give.

MD&A supplies the 'why' behind a number, but management writes it about itself.

MD&A is unaudited and authored by management, so it can lean optimistic; weigh its claims against the audited statements.

Also called
MD&A管理层讨论与分析经营层讨论与分析